Nephrosant announces $16 million series a, led by davita venture group

San francisco, ca / accesswire / march 16, 2021 / nephrosant, a kidney health spin out of uc san francisco, today announced it has closed its oversubscribed series a funding round of $16 million. davita venture group led the investment round, with participation from digitaldx ventures and other previous investors.
DVA Ratings Summary
DVA Quant Ranking